ESRRA and gastric cancer: Previous study in gastric cancer demonstrated that silencing of the transcription factor estrogen-related receptor alpha (ESRRA) downregulates DSN1, leading to inhibition of the CDC25C-CDK1-Cyclin B1 pathway and subsequent G2/M arrest 45.